Abstract:The current study aimed to synthesize seven new metal coordination complexes ( Q1–Q7 ) with potential biomedical applications. Novel mononuclear, polynuclear and mixed-ligand coordination compounds of the elements, cadmium( II ) and silver( I ) derived from a pyridine containing ligand (2,4,6-tris-(2-pyridyl)-1,3,5-triazine ( TPT )) have been synthesized successfully with the general formulae [Cd( TPT )Cl 6 ]·H 2 O and [Ag x ( TPT ) y (L) 2 (ClO 4 )](ClO 4 ) z ( x = 1,2,3, y = 1,2,3, L = PPh 3 or phen, z = 1,2). The structural features were fully characterized using various spectroscopic techniques, such as infrared, ultraviolet-visible spectroscopy, 1D and 2D-NMR ( 1 H, 13 C, 31 P, 1 H– 1 H COSY and 1 H– 13 C HSQCAD), CHN analysis, molar conductance ( Λ ), thermogravimetric analysis (TGA), and powder X-ray diffraction analysis. The structure of complex Q6 was also confirmed by single-crystal X-ray analysis. The luminescence and electrochemical properties of complexes, in solution, have been studied. X-ray crystallographic determination of the [Ag( TPT )(PPh 3 ) 2 ]ClO 4 ·EtOH ( Q6 ) complex shows that the Ag + cation is bonded to one tridentate TPT ligand through NNN set of donor atoms and two triphenylphosphine ligands, giving the Ag + a distorted trigonal bipyramidal geometry. X-ray powder diffraction analysis showed that metal complexes Q3 , Q6 and Q7 display crystalline peaks. The complexes were evaluated for their in vitro antibacterial efficacy against various bacterial and fungal species. The in vitro efficacy against the MCF-7 human breast cancer cell line was assessed to determine the anticancer activities. The tri-nuclear silver complex Q3 shows great potential as a therapeutic candidate for treating breast cancer, since it exhibits a half-maximal inhibition concentration (IC 50 ) of 13.45 ± 0.9 μM. Molecular docking simulations were also carried out to evaluate the interaction strength and properties of the metal complexes with selected cancer and bacteria relevant proteins namely cyclin-dependent kinase 2 (CDK2), cyclin-dependent kinase 6 (CDK6), signal transducer and activator of transcription 3 (STAT3), and beta-lactamases from Escherichia coli and Staphylococcus aureus .

Anti‐Breast Cancer Stem Cell Properties of Silver(I)‐Non‐steroidal Anti‐Inflammatory Drug Complexes

The Anti-Breast Cancer Stem Cell Potency of Copper(I)-Non-Steroidal Anti-Inflammatory Drug Complexes

The Anti‐Cancer Stem Cell Properties of Copper(II)‐Terpyridine Complexes with Attached Salicylaldehyde Moieties

Gd-metallofullerenol Nanomaterial As Non-Toxic Breast Cancer Stem Cell-Specific Inhibitor

Self-Assembling Metallocomplexes of the Amphiphilic 1,4-Diazabicyclo[2.2.2]octane Derivative as a Platform for the Development of Nonplatinum Anticancer Drugs

Silver(I) complexes containing N-heterocyclic carbene azole drugs: Synthesis, characterization, cytotoxic activity, and their BSA interactions

Mesoporous Silica Nanoparticles Enhance the Anticancer Efficacy of Platinum(IV)-Phenolate Conjugates in Breast Cancer Cell Lines

Copper complexes suppress stemness, reverse EMT progression and induce apoptosis on triple negative breast cancer

Synthesis, structure and biological activity of silver(I) complexes containing triphenylphosphine and non-steroidal anti-inflammatory drug ligands

A novel copper(II) complex with salicylidene carbohydrazide ligand that promotes oxidative stress and apoptosis in triple negative breast cancer cells

Cadmium and silver complexes of a pyridine containing ligand: syntheses, structural studies, biological activity and docking studies

Cobalt(III)–Macrocyclic Scaffolds with Anti-Cancer Stem Cell Activity

Synthesis, characterization, crystal structure and anticancer study of symmetrical binuclear bis-N-heterocyclic carbene silver(I) complexes

Anticancer Effect of PtIIPHEN SS, PtII5ME SS, PtII56ME SS and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer

Design, synthesis and anticancer evaluation of novel Se-NSAID hybrid molecules: Identification of a Se-indomethacin analog as a potential therapeutic for breast cancer.

Synthesis and Anticancer Activities of some Ag(I) Complexes Involving N‐Heterocyclic Carbene Ligands

Designing metal chelates of halogenated sulfonamide Schiff bases as potent nonplatinum anticancer drugs using spectroscopic, molecular docking and biological studies

SBA‐15 Particles as Carriers for a series of Platinum(IV) Complexes with Oxaliplatin Scaffolds Bearing Different Anti‐Inflammatory Drugs: Promising Strategy Against Breast Cancer

Anti-oncogenic Potential and Inflammation Modulatory Response of Green Synthesized Biocompatible Silver Nanoparticles

Anticancer potential of Cu(II)prolinedithiocarbamate complex: design, synthesis, spectroscopy, molecular docking, molecular dynamic, ADMET, and in-vitro studies

Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity